284 related articles for article (PubMed ID: 32971151)
1. Use of SGLT2 inhibitors during Ramadan: An expert panel statement.
Hassanein M; Bashier A; Randeree H; Abouelmagd M; AlBaker W; Afandi B; Abu Hijleh O; Shaltout I; Ei-Sharkawy M; Dagdelen S; Assaad Khalil S
Diabetes Res Clin Pract; 2020 Nov; 169():108465. PubMed ID: 32971151
[TBL] [Abstract][Full Text] [Related]
2. Managing People with Diabetes Fasting for Ramadan During the COVID-19 Pandemic: A South Asian Health Foundation Update.
Hanif S; Ali SN; Hassanein M; Khunti K; Hanif W
Diabet Med; 2020 Jul; 37(7):1094-1102. PubMed ID: 32333691
[TBL] [Abstract][Full Text] [Related]
3. Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes.
Abdelgadir E; Rashid F; Bashier A; Al Saeed M; Khalifa A; Alawadi F; Hassanein M
Diabetes Metab Syndr; 2019; 13(5):2927-2932. PubMed ID: 31425958
[TBL] [Abstract][Full Text] [Related]
4. Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population-an observational study from a tertiary care center in Karachi.
Sheikh A; Das B; Sattar S; Islam N
Endocrine; 2023 Apr; 80(1):64-70. PubMed ID: 36580199
[TBL] [Abstract][Full Text] [Related]
5. Diabetes Canada Position Statement for People With Types 1 and 2 Diabetes Who Fast During Ramadan.
Bajaj HS; Abouhassan T; Ahsan MR; Arnaout A; Hassanein M; Houlden RL; Khan T; Khandwala H; Verma S
Can J Diabetes; 2019 Feb; 43(1):3-12. PubMed ID: 29804943
[TBL] [Abstract][Full Text] [Related]
6. Influence of sodium-glucose Co-transporter 2 inhibitors on clinical and biochemical markers of dehydration during the Holy Ramadan.
Gameil MA; Marzouk RE; El-Sebaie AH; Eldeeb AAA
Diabetes Metab Syndr; 2022 Sep; 16(9):102606. PubMed ID: 36063675
[TBL] [Abstract][Full Text] [Related]
7. Evolving physicians' perceptions and practices regarding use of SGLT2 inhibitors for type 2 diabetes during Ramadan fasting.
Beshyah SA; Hafidh K; Shaikh TG
Diabetes Res Clin Pract; 2020 Oct; 168():108389. PubMed ID: 32858101
[TBL] [Abstract][Full Text] [Related]
8. Diabetes during Ramadan - PRE-approach model: presentation, risk stratification, education.
Hassan A; Meo SA; Usmani AM; Shaikh TJ
Eur Rev Med Pharmacol Sci; 2014; 18(12):1798-805. PubMed ID: 24992624
[TBL] [Abstract][Full Text] [Related]
9. Diabetes during Ramadan: underestimated, under-investigated, needs more attention.
Hassan A; Meo SA
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3528-33. PubMed ID: 25491633
[TBL] [Abstract][Full Text] [Related]
10. [Diabetes and Ramadan].
Zantar A; Azzoug S; Belhimer F; Chentli F
Presse Med; 2012 Nov; 41(11):1084-8. PubMed ID: 22959493
[TBL] [Abstract][Full Text] [Related]
11. Treatment Options for Patients with Type 2 Diabetes Mellitus during the Fasting Month of Ramadan.
Loh HH; Kamaruddin NA
Ann Acad Med Singap; 2020 Jul; 49(7):468-476. PubMed ID: 33000110
[TBL] [Abstract][Full Text] [Related]
12. Practical management of diabetes during Ramadan fasting.
Fariduddin M; Mahtab H; Latif ZA; Siddiqui NI
Mymensingh Med J; 2011 Jul; 20(3):541-6. PubMed ID: 21804526
[TBL] [Abstract][Full Text] [Related]
13. A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting.
Rashid F; Abdelgadir E
Diabetes Metab Syndr; 2019; 13(2):1413-1429. PubMed ID: 31336501
[TBL] [Abstract][Full Text] [Related]
14. Guidelines for managing diabetes in Ramadan.
Ali S; Davies MJ; Brady EM; Gray LJ; Khunti K; Beshyah SA; Hanif W
Diabet Med; 2016 Oct; 33(10):1315-29. PubMed ID: 26802436
[TBL] [Abstract][Full Text] [Related]
15. Diabetes and Ramadan: Practical guidelines.
Hassanein M; Al-Arouj M; Hamdy O; Bebakar WMW; Jabbar A; Al-Madani A; Hanif W; Lessan N; Basit A; Tayeb K; Omar M; Abdallah K; Al Twaim A; Buyukbese MA; El-Sayed AA; Ben-Nakhi A;
Diabetes Res Clin Pract; 2017 Apr; 126():303-316. PubMed ID: 28347497
[TBL] [Abstract][Full Text] [Related]
16. Options for Controlling Type 2 Diabetes during Ramadan.
Almalki MH; Alshahrani F
Front Endocrinol (Lausanne); 2016; 7():32. PubMed ID: 27148163
[TBL] [Abstract][Full Text] [Related]
17. The South Asian Health Foundation (UK) guidelines for managing diabetes during Ramadan.
Hanif W; Patel V; Ali SN; Karamat A; Saeed M; Hassanein M; Syed A; Chowdhury TA; Farooqi A; Khunti K
Diabetes Res Clin Pract; 2020 Jun; 164():108145. PubMed ID: 32335096
[TBL] [Abstract][Full Text] [Related]
18. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan.
Bravis V; Hui E; Salih S; Mehar S; Hassanein M; Devendra D
Diabet Med; 2010 Mar; 27(3):327-31. PubMed ID: 20536496
[TBL] [Abstract][Full Text] [Related]
19. [Management of diabetes during Ramadan fasting: applications of international recommendations in clinical practice].
Elamari S; Elaziz S; Chadli A; Farouqi A
Pan Afr Med J; 2020; 36():316. PubMed ID: 33193970
[TBL] [Abstract][Full Text] [Related]
20. Clinical practice points for diabetes management during RAMADAN fast.
Sadikot S; Jothydev K; Zargar AH; Ahmad J; Arvind SR; Saboo B
Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S811-S819. PubMed ID: 28629656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
